A study of the association between adverse drug reaction and genetic testing: developing a genetic testing and surveillance system for severe adverse drug reaction

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEN, Wan Chun (E-DA Hospital, Pharmacy, Kaohsiung, China Taiwan)
  • Co-author(s): Wang Chun Chen: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Hsiu Ling Chang: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Yi Ping Hsiang: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Chi Hsien Huang: Family Medicine, E-DA Hospital, Kaohsiung, Taiwan, Province of China
  • Abstract:

    Methods

    We develop a genetic testing and surveillance system can control the drug genetic test results, avoid patients because of positive test results and lead to serious adverse reactions after using drugs.

    Results

    In case part of the study since 2011 to 2016, included 840 patients with genetic testing, gene HLA-B 1502 executed a total of 620,..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login